Dean Jay Hess, MD, PhD, MHSA, reflects on more than a decade of leadership at IU School of Medicine and why he calls it “one of the best jobs imaginable.”
Read more: https://t.co/65ofrcieOi
The BEHOLD-1 trial shows more than 60% response rate for morcertatug rezetecan (Mo-Rez) in recurrent ovarian and endometrial cancers.
The cancer center's Jessica Parker, MD, provides insight on its potential in this @SurvivorNetTeam article.
Read more: https://t.co/AXHLBkjqN9.
Proud to launch this pilot for our @IUMedSchool students this summer. Our goal is to prepare our future healthcare workforce to thoughtfully and ethically implement these tools. #meded
As his retirement approaches, IU School of Medicine Dean Jay Hess, MD, PhD, MHSA, will sit down for a fireside chat-style interview about his leadership, proudest moments and hopes for the school's future.
Learn more and register here: https://t.co/rzgp7pM4jp
Michael Feldman, MD, PhD, has been named interim dean of the IU School of Medicine, effective June 1, succeeding Jay L. Hess, MD, PhD, who will retire after serving as one of the nation’s longest-serving medical school deans. Read more: https://t.co/ejBNP0UWzv
Match Day may be over, but the memories will last a lifetime. If you want to relive the moments again, check out our Match Day Recap on YouTube.
Congrats Class of 2026, see you in May for Graduation.
https://t.co/Yckk2mJFtL
Another Match Day is in the books.
So you already know what time it is.
(And if for some reason you didn’t: it’s time to break things down, Winners & Losers style.)
🎥👇
As we celebrate #MatchDay, I offer my sincere congratulations to all who matched, embarking on this important and exciting chapter in your careers. #Match2026#MedicalEducation